Elizabeth Rozek - 28 May 2026 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Reporting relationship: Chief Legal & Admin. Officer
Issuer ticker: SGMT
Reported as of: 28 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jun 2026, 21:14:55 UTC
Prior SEC filing: 20 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Rozek

Key filing fact

Elizabeth Rozek filed Form 4 for Sagimet Biosciences Inc. (SGMT) on 01 Jun 2026.

Key facts

This page summarizes Elizabeth Rozek's Form 4 filing for Sagimet Biosciences Inc. (SGMT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jun 2026, 21:14.

Change

Previous filing in this sequence was filed on 20 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001975022 Primary reporting owner

Rozek Elizabeth

Relationship: Chief Legal & Admin. Officer
Address: SAGIMET BIOSCIENCES INC., 155 BOVET ROAD, SUITE 303, SAN MATEO
Signature: /s/ Elizabeth Rozek
Signature date: 01 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGMT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +100,000
Change %
Price: $0.000000^*
Shares after: 100,000
Date: 28 May 2026
Ownership: Direct
Underlying class: Series A Common Stock
Underlying amount: 100,000
Exercise price: $7.27
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following May 28, 2026, subject to the Reporting Person's continued service on each such vesting date.